SLIMLYF COMBINATION PRODUCT CAPSULE

Indications

• Vitamin C deficiency
• Scurvy
• Adjunct therapy in iron overload conditions

Dosage

Children: Child 1 month–3 years: 125–250 mg daily in 1–2 divided doses; Child 4–11 years: 250–500 mg daily in 1–2 divided doses; Child 12–17 years: 0.5–1 g daily in 1–2 divided doses.

Adults: 500 mg daily, taken in 1-2 divided doses, depending on the clinical condition and dietary needs.

Mechanism of action

Ascorbic acid functions primarily as a reducing agent, facilitating enzymatic reactions in the body, including the hydroxylation of proline and lysine in collagen synthesis. It also plays a role in the absorption of iron from the gastrointestinal tract and enhances the immune response.

Pharmacodynamics

Ascorbic acid is crucial for the maintenance of connective tissue and is involved in the metabolism of several amino acids. Its antioxidant properties help to mitigate oxidative stress and may play a role in reducing the risk of chronic diseases.

Pharmacokinetics

Ascorbic acid is absorbed in the intestines and is widely distributed throughout the body. The renal clearance of ascorbic acid is dose-dependent, with higher doses leading to increased excretion. The half-life varies but is generally around 15 to 30 minutes in healthy individuals, with tissue saturation levels influencing its retention.

Contra-indications

• Hypercalcaemia
• Hyperoxaluria
• Patients with cardiac dysfunction

Adverse effects

• Abdominal pain
• Headache
• Nausea
• Vomiting
• Diarrhoea
• Constipation
• Weight loss
• Polyuria
• Sweating
• Thirst
• Vertigo

Interactions

• Increases risk of cardiovascular adverse effects with iron chelators
• Increases risk of cardiovascular adverse effects with deferiprone
• Increases risk of cardiovascular adverse effects with desferrioxamine

Precautions

• Use with caution in patients with iron overload
• Monitor for symptoms of overdose

Pregnancy

High doses teratogenic in animals but therapeutic doses unlikely to be harmful.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Ascorbic acid 50 mg tablets
• Ascorbic acid 100 mg tablets
• Ascorbic acid 200 mg tablets
• Ascorbic acid 250 mg tablets
• Ascorbic acid 500 mg capsules

Indications

• Weight management
• Reduction of cholesterol levels
• Support in dietary fat absorption

Dosage

Children: Refer to specific product guidelines as pediatric dosages are not well established.

Adults: Refer to specific product guidelines as dosages may vary widely based on formulation and concentration.

Mechanism of action

Chitosan acts primarily through its ability to bind dietary fats and cholesterol in the gastrointestinal tract, forming a complex that is not absorbed by the body. This mechanism reduces the absorption of fats and can lead to decreased calorie intake. Additionally, it may influence lipid metabolism and promote fat excretion.

Pharmacodynamics

Chitosan exhibits a high degree of biocompatibility and is non-toxic, which allows it to be safely ingested. Its lipid-binding properties contribute to a reduction in serum cholesterol levels and may help in weight management. The effects on lipid profiles are attributed to its ability to inhibit the absorption of dietary lipids and cholesterol.

Pharmacokinetics

Chitosan is not absorbed through the gastrointestinal tract due to its high molecular weight and polymeric structure. It passes through the digestive system largely unchanged. The effects of chitosan are primarily localized to the gut, where it interacts with dietary fats and cholesterol. Its elimination is through fecal excretion.

Adverse effects

• Gastrointestinal discomfort
• Nausea
• Constipation
• Diarrhea
• Flatulence

Precautions

• Use with caution in individuals with shellfish allergies, as chitosan is derived from chitin found in shellfish.
• Monitor for gastrointestinal side effects, particularly in patients with pre-existing digestive disorders.

Pregnancy

Chitosan is generally considered safe in pregnancy, but its effects have not been extensively studied. Consultation with a healthcare provider is recommended.

Breast-feeding

Chitosan is likely safe during breastfeeding, but limited data are available. Consultation with a healthcare provider is recommended.

Storage

Store in a cool, dry place, away from direct sunlight and moisture.

Formulations

• Capsules
• Tablets
• Powder

Indications

• Herbal medicine for various ailments
• Nutritional supplementation
• Flavoring agents in food
• Support for digestive health
• Management of stress and anxiety

Dosage

Children: Paediatric dosing is dependent on the specific extract and should be determined based on the product guidelines or consulting a healthcare professional familiar with herbal medicine.

Adults: Dosage varies widely based on the specific extract and condition being treated. Refer to product-specific guidelines or consult relevant pharmacological literature for appropriate dosing.

Mechanism of action

The mechanism of action of extracts varies depending on the source material and the specific compounds present. Common mechanisms include modulation of neurotransmitter systems, anti-inflammatory effects, antioxidant activity, and interaction with various cellular pathways. For example, flavonoids in plant extracts may exert antioxidant effects by scavenging free radicals, while alkaloids may influence neurotransmitter receptors.

Pharmacodynamics

The pharmacodynamics of extracts depends on their composition. They may exhibit various effects, such as anti-inflammatory, analgesic, antimicrobial, and immunomodulatory activities. The pharmacological effects are often dose-dependent, with lower doses providing therapeutic benefits and higher doses potentially leading to adverse effects. The time course of action can also vary, with some extracts providing rapid relief and others requiring chronic use to achieve efficacy.

Pharmacokinetics

The pharmacokinetics of extracts depend on the specific compounds and their properties, including solubility, stability, and absorption. Typically, active constituents are absorbed in the gastrointestinal tract and may undergo first-pass metabolism in the liver. The distribution of compounds can vary, affecting their bioavailability and the duration of action. Elimination routes may include renal excretion or metabolic conversion to inactive forms.

Pregnancy

Safety during pregnancy varies depending on the specific extract. Consult specific extract guidelines.

Breast-feeding

Safety during breastfeeding varies depending on the specific extract. Consult specific extract guidelines.

Storage

Store in a cool, dry place away from direct sunlight, and keep out of reach of children.

Indications

• Wound healing
• Skin ulceration
• Burns
• Psoriasis
• Dermatitis

Dosage

Children: Refer to the BNF for Children for appropriate dosing information based on the child's age and condition.

Adults: Refer to the BNF for specific formulations and dosing guidelines, as dosages may vary based on the condition being treated and the formulation used.

Mechanism of action

While there is no well-controlled data to formally substantiate the method of action, ongoing studies suggest that allantoin may induce a histological wound healing profile in animal models, leading to improved reestablishment of normal skin. This includes increased vasodilation, inflammatory cell presence, angiogenesis, fibroblast proliferation, and collagen deposition in treated wounds compared to untreated ones.

Pharmacodynamics

There is limited controlled data regarding the pharmacodynamic properties of allantoin. However, studies indicate that allantoin may possess moisturizing and keratolytic effects, increasing the extracellular matrix's water content and enhancing the desquamation of dead skin cells. These activities can promote cell proliferation and facilitate wound healing.

Pharmacokinetics

Specific pharmacokinetic data for allantoin in humans is limited. However, it is known to be applied topically, which suggests local absorption at the site of application. Systemic absorption is considered minimal due to its low molecular weight and hydrophilicity.

Pregnancy

There is limited data on the safety of allantoin in pregnancy. It is advisable to consult a healthcare professional before use.

Breast-feeding

Allantoin is generally considered safe during breastfeeding, but caution is recommended. Consult a healthcare professional before use.

Storage

Store at room temperature, away from direct sunlight and moisture. Keep out of reach of children.

Formulations

• Topical cream
• Gel
• Ointment

Mechanism of action

There is no well controlled data that can formally substantiate the method of action. However, ongoing studies suggest that there may exist a histological wound healing profile induced by allantoin in rats that leads to the amelioration and fastening of the reestablishment of normal skin. This facilitation of wound healing is supported by observations that wounds inflicted to rat subjects to which topical allantoin preparations were applied histologically demonstrated increased vasodilation, presence of inflammatory exudates, number of inflammatory cells, angiogenesis, fibroblast proliferation, and increased collagen deposition when compared to rat subjects with wounds that did not receive any allantoin administration.

Pharmacodynamics

There is no well controlled and appropriate data that can formally substantiate the pharmacodynamic properties of allantoin. Nevertheless, ongoing studies suggest that allantoin possesses moisturizing and keratolytic effects, as well as abilities to increase the water content of the extracellular matrix and enhance the desquamation of upper layers of dead skin cells, all of which are activities that can promote cell proliferation and facilitate wound healing.